Pharmaceuticals
Eirgenix Receives Approval from Japan's PMDA
TAIPEI, Feb. 14, 2020 /PRNewswire/ -- EirGenix, Inc. (6589, TT) had undertaken the transfer of drug substance manufacturing of a marketed drug from a Japanese pharmaceutical company and has since fulfilled all the regulatory requirements necessary to complete the manufacturing site transfer. The ...
2020-02-14 15:14
2786
Sihuan Pharmaceutical Accelerates Product Expansion in Digestive System and Liver Related Diseases
HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the progress achieved by the Group in the research and development of drugs for treati...
2020-02-14 10:35
7464
Sirtex Medical announces collaboration with MIM Software Inc.
Partnership advances innovation and increases precision of liver-directed oncology therapies for patients WOBURN, Massachusetts, Feb. 12, 2020 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced a collaboration with MIM Software Inc., a lead...
2020-02-12 22:00
1679
Sihuan Pharmaceutical and Hetero Labs Limited Reached A Framework Cooperation Agreement in Pharmaceutical Manufacturing Area
HONG KONG, Feb. 12, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the Group and Hetero Labs Limited ("Hetero"), a company registered under the laws ofI...
2020-02-12 05:00
7934
IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs
MENLO PARK, California, Feb. 12, 2020 /PRNewswire/ -- IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in im...
2020-02-12 03:25
2263
Vakrangee to Revolutionize Rural Healthcare in India: Plans to Rollout Telemedicine Services From vHealth by AETNA (a CVS Health Company)
MUMBAI, India, Feb. 11, 2020 /PRNewswire/ -- Vakrangee Limited (VL) announces alliance with vHealth by Aetna which is fully owned subsidiary of Aetna Inc, a CVS Health Company (Fortune 8 enterprise), one of the world's leading health services providers, to offer a combination of Telemedicine serv...
2020-02-11 16:42
3910
Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020
PHILADELPHIA and LONDON, Feb. 10, 2020 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced the launch of its annual Cortellis "Drugs to Watch " list, which identifies 11 new...
2020-02-10 21:42
5094
Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)
- RRP is a rare, potentially fatal orphan disease caused by Human Papillomavirus (HPV) 6 and 11 - Inovio's DNA medicine pipeline includes 15 clinical programs focused on HPV-associated diseases, cancer, and infectious diseases, including the novel coronavirus (2019-nCoV) PLYMOUTH MEETING, Penns...
2020-02-10 19:00
2795
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
NANJING, China, Feb. 10, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District, Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CA...
2020-02-10 10:49
1964
RhoVac Announces Appointment of Professor Anne J. Ridley to its Scientific Advisory Board
STOCKHOLM, Feb. 6, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, 6 th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition ofAnne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, ...
2020-02-06 20:22
1420
Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer
MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study
2020-02-06 08:00
2364
Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO
STOCKHOLM, Sweden, Feb. 5, 2020 /PRNewswire/ -- Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEOCecilia Edström as new CEO of Bactiguard andStefan Grass (CMO) as Deputy CEO. ...
2020-02-05 06:38
11255
Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities
SYDNEY, Feb. 4, 2020 /PRNewswire/ -- Pharmacy Alliance has established a
bushfire appeal, aiming to raise$250,000 to support bushfire affected
pharmacies in providing free medication and personal care items to their
communities.
2020-02-04 08:15
1774
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases
SEATTLE, Feb. 4, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114. Trefoil is developing products based...
2020-02-04 06:00
1880
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...
2020-02-03 21:00
2435
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies
Increased acceptance of outsourcing clinical trials predicted to propel sector revenues to$71.7 billion by 2024 SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ -- With an overall R&D expenditure of$167 billion in 2018, the global healthcare industry is investing heavily in the development of nove...
2020-02-03 17:01
1475
GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma
- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...
2020-02-03 17:00
9182
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Recent clinical studies presented at International Symposium organized by Fondazione Internazionale Menarini The World Health Organization warns: invest more and invest now in research to avoid catastrophic consequences for public health FLORENCE, Italy, Jan. 30, 2020 /PRNewswire/ -- The introdu...
2020-01-30 23:09
2470
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Agreement will facilitate clinical trial translations in China PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development inChina of INO-4800, Inovio'...
2020-01-30 19:00
4213
Infinitus donates 6 million yuan in cash and supplies to support prevention and treatment efforts in dealing with 2019-nCoV
GUANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In the last few days, all attention inChina is focused on the prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV). Medical staff from both Wuhan and around the country, as well as people from all walks of life, are ...
2020-01-29 21:04
2194
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 305 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 299 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 283 media titles]
2024-11-20 09:00
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8674
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5354
Yingli Solar's Global Product Workshops Launched in Malaysia
2024-11-15 21:40
4730
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
4681